Wellgistics Health has filed an S-1 registration statement with the Securities and Exchange Commission detailing a plan to integrate XRP and the XRP Ledger (XRPL) across its payments and treasury operations.
The Nasdaq-listed health-tech company said it will use XRPL to process real-time, low-cost business-to-business payments among pharmacies, manufacturers, and vendors and expand its XRP holdings.
The filing states the company may raise capital through equity and debt offerings to purchase additional XRP, deploy those holdings to generate income, and use the asset as collateral for future financing. The disclosure follows a $50 million equity financing commitment from LDA Capital, which the company said will fund XRPL infrastructure and related initiatives.
What I have gathered from reading the S-1 form filed with the SEC today by Wellgistics Health is incredibly revealing. It is more than just a company using XRP in its treasury reserve.
This is a summary of what the filing revealed:
1. WH is not only planning to hold XRP as a…
— bill morgan (@Belisarius2020) July 25, 2025
The S-1 positions XRP as an active balance sheet instrument. Wellgistics said it intends to accumulate XRP and apply it to several functions: as a payments rail, as collateral to secure financing, and as a source of income generation.
The company indicated that treating XRP as collateral could provide liquidity without disrupting operations. It also outlined plans to raise capital specifically for digital asset acquisition, signaling that future issuances of equity or debt may be tied to enlarging its XRP position.
XRPL to underpin B2B settlements across the company’s network
According to the filing, Wellgistics will implement XRPL to support near-instant settlement and reduced fees for business partners. The company identified a network of approximately 6,000 pharmacies and 150 manufacturers that will interface with the XRPL-based system. The stated objective is to streamline value transfer and improve liquidity across that ecosystem by avoiding the delays and costs present in traditional payment systems.
Ripple legal expert Bill Morgan described the filing as evidence of XRP’s real-world use. He said the S-1 shows that XRP is being incorporated into a corporate operating model and is not held solely for speculative purposes.
Capital plan references $50M LDA line
Wellgistics said LDA Capital committed $50 million in equity financing, enabling the company to issue shares and draw funds as needed. The company linked that facility to the buildout of its XRPL payment platform and the expansion of its XRP position. Beyond the LDA arrangement, the S-1 states that Wellgistics may pursue additional equity and debt offerings to finance XRP purchases and related infrastructure.
The company also disclosed plans to seek income from its XRP holdings. The filing frames this as an initiative to increase balance sheet efficiency and deploy XRP within core payment flows.
Additionally, the S-1 includes risk disclosures tied to XRP’s regulatory status and ongoing litigation. Wellgistics warned that adverse legal or regulatory outcomes could affect XRP’s price and, as a result, the value of the company’s treasury assets and collateral. The filing also acknowledges public concerns about XRP’s utility. In response, the company presented its operational use of XRPL as a direct, measurable application within its logistics model.
Wellgistics referenced a May announcement that it would adopt XRP to improve speed, data transparency, and operational efficiency. CEO Brian Norton pointed out a deliberate reliance on infrastructure-led innovation rather than traditional expansion.Â
